
Orion is a globally operating Nordic pharmaceutical company – a builder of well-being.
Read moreStock exchange releases
- 5/2/2025 301,521 Orion Corporation A shares converted into B shares
- 4/24/2025 Composition of the Nomination Committee of Orion Corporation
- 4/23/2025 Orion Group Interim Report January–March 2025
- 4/10/2025 The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence
Press releases
- 5/23/2025 Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market
- 5/22/2025 Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
- 5/21/2025 Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
- 4/25/2025 Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease